Related Experiment Video

Updated: Jun 8, 2026

In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

Angiogenesis and the heart

Shree G Sharma1, Sudip Nanda, Santo Longo

  • 1Department of Pathology, University of Arkansas, Arkansas, USA. drshreegopal@gmail.com

Recent Patents on Cardiovascular Drug Discovery
|September 30, 2010
PubMed

Insights

Cardiovascular disease is rising globally. This review explores new angiogenesis treatments and patents for cardiac patients lacking other options.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Biotechnology

Background:

  • Global incidence of cardiovascular disease is increasing.
  • Many cardiac patients are unsuitable for current treatments, creating a 'no-option' subgroup.
  • This subgroup drives innovation in cardiac angiogenesis therapies.

Purpose of the Study:

  • To review current treatment modalities for cardiac angiogenesis in 'no-option' patients.
  • To discuss patents filed to advance cardiac angiogenesis.
  • To highlight the importance of developing new therapies for this patient population.

Main Methods:

  • Literature review of treatment modalities for cardiac angiogenesis.
  • Analysis of filed patents related to cardiac angiogenesis.
  • Synthesis of information on therapeutic approaches and intellectual property.

Main Results:

  • Several treatment modalities are being explored for cardiac angiogenesis.
  • Numerous patents have been filed, indicating significant research and development activity.
  • The field of cardiac angiogenesis is rapidly evolving in response to unmet clinical needs.

Conclusions:

  • Angiogenesis offers a promising therapeutic avenue for 'no-option' cardiovascular patients.
  • Ongoing research and patent filings underscore the potential of this field.
  • Further development is crucial to translate these advancements into clinical practice.

More Related Videos

The Arteriovenous (AV) Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering08:53

The Arteriovenous (AV) Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering

Published on: November 2, 2016

Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells09:24

Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells

Published on: September 18, 2019

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...